Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aura Biosciences, Inc. | Director | Common Stock | 21K | $163K | $7.75 | Mar 31, 2025 | Direct |
Aura Biosciences, Inc. | Director | Stock Option (Right to Buy) | 29K | Mar 31, 2025 | Direct | ||
Fusion Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 0 | Jun 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AURA | Aura Biosciences, Inc. | Mar 31, 2025 | 2 | $0 | 4 | Apr 2, 2025 | Director |
AURA | Aura Biosciences, Inc. | Mar 31, 2025 | 0 | $0 | 3 | Apr 2, 2025 | Director |
FUSN | Fusion Pharmaceuticals Inc. | Jun 4, 2024 | 1 | $0 | 4 | Jun 4, 2024 | Director |
FUSN | Fusion Pharmaceuticals Inc. | Oct 16, 2023 | 1 | $0 | 4 | Oct 16, 2023 | Director |
FUSN | Fusion Pharmaceuticals Inc. | Oct 16, 2023 | 0 | $0 | 3 | Oct 16, 2023 | Director |